Nobody has written clearer rules about cannabis and surgery than anesthesiologists, and the rules are calmer than the internet. The 2023 ASRA Pain Medicine consensus guideline tells its members to ask every patient about cannabis, to postpone an elective operation only for acute intoxication or a smoke within the last two hours, and to set no waiting period for edibles, because the evidence to set one does not exist. It does not tell anyone to cancel surgery over a nightly gummy. It does tell anesthesiologists to counsel against use around the operation, and to plan for a patient who needs more propofol and wakes up in more pain.

Our position is that the one bad option is silence. Every recommendation in that document runs off the answer to a screening question, and a patient who answers it wrong gets an anesthetic planned for a different body. The airway and heart-attack worries belong to smoking. For an edible user the practical issues are food (a gummy is a solid under the fasting rules), time (an edible runs 4 to 8 hours, longer at higher doses) and the recovery room, where regular users measurably need more of everything.

Tell the surgeon's office before the day, not the anesthesiologist on it. The American Society of Anesthesiologists' patient guidance notes that you often do not meet your anesthesiologist until the morning of surgery, and asks regular users to tell the surgeon's office ahead of time so the anesthesia team can evaluate. If you take dronabinol, nabilone or Epidiolex, the ASA says not to stop it abruptly, and if you use cannabis for a medical reason, to talk to the team before stopping.

Do I have to tell my anesthesiologist about edibles?

Yes, and the guideline expects to be the one asking. Universal screening for cannabis and cannabinoid use before surgery is the ASRA panel's first recommendation and carries its strongest grade, Grade A: product type, route, amount, frequency and time of last use. Routine urine testing gets a Grade D, meaning the panel recommends against it. The answers come from you.

The screen exists because the answers change the plan. The ASA's patient page lists what cannabis use, "including edibles," can affect: the anesthesia you need, heart and breathing risk, pain medication afterwards, nausea, withdrawal, and interactions with other drugs. Its list of the questions an anesthesiologist will ask matches the guideline's screening fields.

The standard pre-op form asks about alcohol in units per week and about cannabis, if at all, in a yes-or-no box, which is quietly absurd. A "yes" with no dose, route or timing gives an anesthesiologist almost nothing. These five answers give them what the guideline says they need:

  1. The product and route: gummy, chocolate, tincture, capsule, smoked or vaped, and THC, CBD-only or a ratio.
  2. The dose, in milligrams of THC per piece and pieces per day, read off the package.
  3. How often and for how long; nightly for three years is a different patient from twice a month.
  4. When the last dose was, to the hour, including anything taken on the morning of surgery.
  5. What it is for, and whether a prescribed cannabinoid is involved.

Patients who do this report it going undramatically. On the ILGM growers' forum in March 2023, a daily user asked whether a minor procedure under sedation meant stopping. Spiney_norman replied that cannabis sits in their medical file, the doctors knew about it for two operations, and all they asked for was seven days without it. Riskguy told the doctor about smoking that morning; the surgery went ahead, the two-hour rule in practice, and went fine.

Will my surgery be cancelled because I use cannabis?

Regular use, by itself, is not a reason the guideline gives. It names two triggers for postponing an elective operation: acute intoxication with altered mental status or impaired decision-making (Grade A), and smoking within the previous two hours, because of heart-attack risk (Grade C). For edibles and non-smoked routes the panel set no waiting period (Grade I, insufficient evidence).

Tapering got the same grade: no recommendation for or against weaning cannabis before surgery (Grade I). What the panel did recommend is counseling, Grade B for counseling patients about the risks of continuing cannabinoids around the operation, and Grade A for telling frequent users that cannabis can worsen postoperative pain control and that low-dose, medically supervised use likely carries less risk. The ASA's patient page puts it in plainer words: a patient can be advised to stop smoking one or more days before surgery "unless you use it for a medical reason."

The 72-hour number on forums comes from earlier perioperative reviews, which the ASRA panel cites alongside a seven-day taper protocol and a ten-day abstinence proposal, and then declines to adopt any of them, grading the timing question for non-smoked routes as insufficient evidence. The Sajdeya, Treggiari and Narouze review (Narouze is the guideline's senior author) notes that the two-hour rule and the older advice to abstain for 72 hours both came out of cardiovascular studies, not studies of how cannabis and anesthetics interact. The one prospective cohort through elective surgery, McAfee and colleagues at Michigan in 2021, found 79 users among 1,335 patients worse on pain, function and anxiety on the day of surgery and no different on surgical site pain or treatment success at six months. The guideline is written for the first days, which is where the differences live.

How long before surgery should I stop taking edibles?

The guideline sets no number, and this page will not invent one. The fasting rule applies, because an edible is food. The ASA fasting guideline allows a light meal up to six hours before an elective procedure and wants eight or more after fried or fatty food. A gummy is a light meal. A chocolate bar is fatty food.

Those windows come from the 2017 guideline, which the 2023 update left alone on solids, and the 2017 text tells clinicians to weigh the amount and the type of food, a polite way of saying a 100mg chocolate bar at 11pm is a different problem from a 5mg gummy at 8pm.

Then there is the drug inside the food. Our guide to how long edibles last owns the numbers: onset 30 minutes to 2 hours, peak 2 to 3 hours after eating, main effects for 4 to 8 hours, with a higher dose stretching the tail toward 12. Run that against a 7am check-in. A gummy at 10pm peaks around midnight and sits inside its main-effect window until somewhere between 2am and 6am; a higher dose is still inside it at 10am. The clock the anesthesiologist cares about is the dose clock, and only the person who took the dose can read it.

One timing carries a clear cost. The Grade A postponement is for a patient who cannot properly consent, and an edible taken on the morning of surgery to calm the nerves is the timing most likely to produce one. The ASA page speaks to exactly this reader: tell the anesthesiologist if you were hoping to use cannabis to sleep, settle anxiety or relax before surgery. They have a pharmacy of things that calm nerves, and none of them sit in the stomach for four hours.

Do cannabis users need more anesthesia?

In the studies that measured it, yes, for propofol. A 2025 meta-analysis of eight studies and 2,268 patients found cannabis users needed 47mg more propofol, about 31mg more under general anesthesia and 53mg more for endoscopy sedation. The guideline's response is a Grade C recommendation to consider adjusting induction and maintenance doses by presentation and time since last use.

The table collects the studies behind that figure and the ones behind the next section, with who was measured and what was found.

StudyWho was measuredWhat was measuredCannabis users against non-users
Flisberg 2009, randomized, single-blind30 men using more than once a week and 30 non-users, aged 18 to 50Propofol to insert a laryngeal mask at induction314mg against 263mg; the dose to reach the target brain-monitor reading was not significantly different
Twardowski 2019, chart review250 endoscopy patients, 25 regular usersPropofol, midazolam and fentanyl for sedationPropofol 44.8mg against 13.8mg, with more midazolam and fentanyl too; P=.05 after adjusting for age, sex, alcohol, benzodiazepines and opiates
Imasogie 2021, case-control318 endoscopy patients, 151 with any reported cannabis exposurePropofol infusion rate0.33 against 0.18 mg/kg/min; three sedation complications in the exposed group, none in the controls
Baker 2025, meta-analysisEight studies, 2,268 patientsPooled extra propofol47.3mg more overall; 30.6mg more under general anesthesia; 53.0mg more for endoscopy sedation
Jefferson 2013, prospective73 elective surgery patients in Jamaica, 42 usersRescue opioid (pethidine) in the first postoperative hours82.7mg against 51.6mg
Liu 2019, propensity-matched155 cannabinoid users and 155 matched non-users after major orthopedic surgeryPain in the first 36 hoursModerate-to-severe pain at rest 62.3% against 45.5%; with movement 85.7% against 75.2%; more interrupted sleep
Salottolo 2018, four trauma centers261 crash patients, 54 usersDaily opioid use and pain score7.6mg against 5.6mg hydromorphone-equivalent a day; pain 4.9 against 4.2 out of 10, in patients using no other drugs
Sajdeya 2025, propensity-matched126 users and 378 non-users aged 65 and overPain and opioids in the first 24 hoursPain 4.68 against 3.88 out of 10; 42.5mg against 30mg oral morphine equivalents
Suhre 2020, two academic centers27,388 general anesthesia patients, 10% chronic usersNausea and vomiting in the recovery unitRelative risk 1.19 for daily use (95% CI 1.00 to 1.45); an absolute increase of 3.3 percentage points
McAfee 2021, prospective1,335 elective surgery patients, 79 usersSelf-reported outcomes at three and six monthsWorse pain and function on the day of surgery; surgical site pain and treatment success no different at follow-up

Flisberg's Swedish trial is the only randomized study on the list, and its result is narrower than the headline. The dose to reach the target reading on the brain monitor was not significantly higher in the cannabis group; the dose to get a laryngeal mask in cleanly was, 314mg against 263mg. The authors' conclusion, that cannabis raises the propofol needed for a satisfactory clinical induction, is a sentence about airway reflexes as much as the brain.

The endoscopy studies are where the big numbers come from. Twardowski's Colorado chart review found 25 regular users among 250 patients, and their propofol came to 44.8mg against 13.8mg, more than three times as much, holding after adjustment for age, sex, alcohol, benzodiazepines and opiates. Its P value is .05, significant by exactly one decimal place. Imasogie's Ontario clinic found 0.33 against 0.18 mg/kg per minute under a single anesthetist. Baker's meta-analysis pooled these and five others into the 47mg figure and spent its conclusion on caveats: no standard definition of a propofol requirement, and users who were younger and more likely to smoke tobacco.

The Narouze review adds the honest caveat: these are associations, with no causation shown and no mechanism known. There is a certain irony in the drug people take to relax making the drug meant to put them under work harder. An anesthesiologist who knows draws up more propofol and watches the monitor. One who does not finds out when the mask will not go in.

Does cannabis make pain and nausea worse after surgery?

The studies say more pain, more opioid and slightly more nausea. Liu's group matched 155 patients on cannabinoids to 155 non-users and found moderate-to-severe pain at rest in 62 percent against 46. Suhre put the nausea increase at 3.3 percentage points for daily users across 27,388 patients. Neither is a reason to hide use; both are reasons to plan.

The pain finding is the most consistent result here. Jefferson's prospective study in Jamaica watched 73 elective patients through their first postoperative hours; the 42 cannabis users needed 82.7mg of rescue pethidine against 51.6mg. Salottolo's four trauma centers found crash victims who used cannabis and nothing else consuming 7.6mg of hydromorphone-equivalent a day against 5.6mg. Sajdeya's Florida cohort of patients 65 and over used 42.5mg of oral morphine equivalents in 24 hours against 30mg. The guideline's answer is unglamorous: multimodal analgesia with regional techniques where appropriate and opioids as rescue, opioids when indicated with extra vigilance, both Grade C, and reassessment. Ladha's 2021 panel in the British Journal of Anaesthesia reached the same place: expect higher analgesic needs, and add nausea prophylaxis.

There is a rarer nausea story the team can only run down if they know the history. Cannabinoid hyperemesis is cyclical vomiting from long-term heavy use; in the Mayo Clinic series of 98 patients, 95 percent of those with frequency recorded used more than once a week, and 91 percent of those who tried it got relief from hot showers. The Narouze review notes that surgical stress can set off an episode and that standard anti-nausea drugs do little for it. A daily user vomiting through ondansetron in recovery is a differential diagnosis only if someone disclosed the daily use.

Withdrawal belongs in the same conversation. The guideline recommends monitoring routine users after surgery with a validated withdrawal scale and, by consensus, low-dose dronabinol for severe cases (both Grade C). Our cannabis use disorder page describes the syndrome; in a hospital bed it reads as irritability, broken sleep and nausea, filed under surgical recovery by a team that does not know about the nightly gummy.

What this means if you take edibles for chronic pain

Most of the people in these studies were smokers, and nobody has run the edible-only cohort, so a nightly 5mg gummy for a bad back is being judged on data from heavier use. The receptor tolerance behind the pain finding builds with regular exposure by any route, though, and the guideline treats frequency as the variable, not the format.

The one sentence in the document written for the medical edible user is the Grade A counseling line: frequent use can worsen postoperative pain control, and low-dose, medically supervised use likely carries less risk. That is the panel saying dose and supervision matter. The ASA adds the practical half: if the use is medical, the conversation about stopping happens with the team before surgery, and that conversation is where the recovery plan gets built, because the multimodal regimen the guideline recommends is replacing something.

What the evidence does not support is an edible for the first days after the operation. The trial record is thin and contradictory, the interactions with opioids and anticoagulants are at their most crowded, and our post-surgical pain page lays out why a gummy on day two is the wrong tool. If the pain turns chronic, the chronic pain page is the one to read, with a pain clinician who knew about the edibles from the start.

This page summarizes published research and reported patient experience. It is not medical advice. Consult a physician before starting any cannabis regimen, particularly if you have an operation scheduled: your surgical and anesthesia team make the decisions around it, and they need to know about your use to make them. Do not stop a prescribed cannabinoid or a medical regimen on your own before surgery.